Kinnate Biopharma
Utility Patents

Last updated:

List of all Kinnate Biopharma patents 8 in total

Status Patent
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 8 Sep 2025 Issue date: 20 Sep 2022
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 8 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 8 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 8 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Inhibitors of fibroblast growth factor receptor kinases External link
Filling date: 8 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 8 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Inhibitors of RAF kinases External link
Filling date: 8 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Inhibitors of cyclin-dependent kinases External link
Filling date: 8 Sep 2025 Issue date: 19 Jan 2021

Showing 1 to 8 of 8 patents.